RISTORI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 10.307
AS - Asia 6.160
EU - Europa 3.776
SA - Sud America 731
AF - Africa 320
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 21.324
Nazione #
US - Stati Uniti d'America 10.131
SG - Singapore 2.366
IT - Italia 1.441
CN - Cina 1.019
VN - Vietnam 771
HK - Hong Kong 661
BR - Brasile 541
IN - India 538
DE - Germania 419
SE - Svezia 328
FI - Finlandia 275
BD - Bangladesh 262
RU - Federazione Russa 241
FR - Francia 224
UA - Ucraina 223
GB - Regno Unito 164
ZA - Sudafrica 142
CA - Canada 94
AR - Argentina 91
JP - Giappone 89
NL - Olanda 78
ID - Indonesia 71
AT - Austria 56
IE - Irlanda 55
IQ - Iraq 52
TR - Turchia 52
KR - Corea 45
BG - Bulgaria 44
MX - Messico 39
ES - Italia 38
CI - Costa d'Avorio 37
RO - Romania 35
TG - Togo 35
PL - Polonia 30
PK - Pakistan 29
BE - Belgio 27
SA - Arabia Saudita 25
VE - Venezuela 25
MA - Marocco 24
AU - Australia 23
EG - Egitto 21
IR - Iran 19
PH - Filippine 19
JO - Giordania 18
CZ - Repubblica Ceca 17
TN - Tunisia 17
CO - Colombia 16
EC - Ecuador 16
LT - Lituania 14
MY - Malesia 14
CH - Svizzera 12
CL - Cile 12
KE - Kenya 12
PY - Paraguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
NP - Nepal 11
TW - Taiwan 11
GR - Grecia 9
PT - Portogallo 9
UY - Uruguay 9
LB - Libano 8
TH - Thailandia 8
AZ - Azerbaigian 7
ET - Etiopia 7
CR - Costa Rica 6
DZ - Algeria 6
IL - Israele 6
OM - Oman 6
PA - Panama 6
PE - Perù 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
AL - Albania 5
BY - Bielorussia 5
KG - Kirghizistan 5
KZ - Kazakistan 5
CY - Cipro 4
DO - Repubblica Dominicana 4
MK - Macedonia 4
DK - Danimarca 3
GE - Georgia 3
GH - Ghana 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
RS - Serbia 3
SC - Seychelles 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
BO - Bolivia 2
EE - Estonia 2
GA - Gabon 2
GD - Grenada 2
HR - Croazia 2
JM - Giamaica 2
Totale 21.293
Città #
Singapore 1.254
Ashburn 1.226
Fairfield 1.184
San Jose 894
Hong Kong 630
Chandler 552
Woodbridge 514
Houston 438
Seattle 438
Cambridge 409
Beijing 341
Wilmington 341
Rome 292
Ho Chi Minh City 260
Los Angeles 243
Santa Clara 206
Princeton 196
Ann Arbor 187
Hanoi 180
Plano 157
Lauterbourg 149
Buffalo 143
Fasano 137
The Dalles 131
Johannesburg 126
Boston 124
New York 123
Lawrence 100
Milan 100
Munich 100
San Paolo di Civitate 93
Frankfurt am Main 92
Dallas 89
Hillsboro 88
San Diego 84
Helsinki 83
Jacksonville 81
Tokyo 73
Cosenza 67
Dearborn 66
Moscow 63
Millbury 59
Boardman 51
Norwalk 51
Andover 50
Jakarta 49
Redondo Beach 48
Turku 48
Dublin 47
Toronto 45
São Paulo 43
Nuremberg 42
Sofia 42
Chicago 41
Council Bluffs 41
Da Nang 38
Abidjan 37
Federal 37
Des Moines 36
Lomé 35
Vienna 35
Bremen 31
Haiphong 30
Falls Church 29
London 29
Guangzhou 28
Bengaluru 27
Falkenstein 26
Brussels 25
Montreal 25
Pune 25
Paris 23
Warsaw 23
Istanbul 22
Amsterdam 21
Hefei 21
Naples 21
Orem 21
Atlanta 20
Biên Hòa 20
Chennai 20
Phoenix 19
San Mateo 19
Yubileyny 18
Belo Horizonte 17
Casablanca 17
Florence 17
Baghdad 16
Lappeenranta 16
Tianjin 16
Bühl 15
Miano 15
Rio de Janeiro 15
Amman 14
Grafing 14
Nanjing 14
Salt Lake City 14
San Francisco 14
Jeddah 13
Mannheim 13
Totale 13.712
Nome #
Clinical and genetic characteristics of late-onset Huntington's disease 310
A case of double standard. Sex differences in multiple sclerosis risk factors 258
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate 218
CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis 210
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial 199
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 194
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review 188
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study 181
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 177
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases 177
A linkage analysis of multiple sclerosis with candidate region markers in Sardinian and continental Italian families 175
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 171
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 171
Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis 168
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 166
The contribution of gut barrier changes to multiple sclerosis pathophysiology 164
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia 164
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 162
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 161
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients 160
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 159
arsenical c-glucoside derivatives with promising antitumor activity 158
Bacille calmette guerin (BCG) vaccine in multiple sclerosis (MS): A single crossover study 156
Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes 156
A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population. 153
Disentangling multiple sclerosis phenotypes through mendelian disorders: A network approach 152
Dendritic cells loaded with apoptotic oligodendrocytes as a source of myelin T-cell epitopes in multiple sclerosis 151
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report 151
Circulating hsa-miR-323b-3p in Huntington's Disease. A Pilot Study 151
Association between vaccines and neuroinflammation. time, risks, and benefits 149
Exploring the structural relationship between interviewer and self-rated affective symptoms in Huntington’s disease 148
Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? 148
IFN-β and multiple sclerosis: From etiology to therapy and back 147
Huntington's Disease. Prevalence and Psychological Indicators of Pain 146
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease 145
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 145
The Italian Twin Project: From the personal identification number to a national Twin Registry 141
Twin studies in multiple sclerosis. A meta-estimation of heritability and environmentality 141
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 141
Epstein-Barr virus genetic variants are associated with multiple sclerosis 141
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 141
Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies 140
Chapter 3 - Bacille Calmette-Guérin (BCG) Vaccine in Neuroinflammation 140
Spinocerebellar ataxia type 3 in Italy. time to change mind 139
T cell response to N-formylated peptides in humans 138
Vaccines in multiple sclerosis. The experience of BCG vaccination 138
Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis. 137
Anatomical and functional correlates of cognitive deficit in multiple sclerosis. 137
Riluzole in patients with hereditary cerebellar ataxia. Authors' reply 137
Genome-Wide Multiple Sclerosis Association Data and Coagulation 137
Perinatal insults and neurodevelopmental disorders may impact Huntington's disease age of diagnosis 137
Biomarkers for multiple sclerosis 136
The T cell response to amyloid-beta to mitochondrial antigens in Alzheimer's disease 136
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 136
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis 136
Chemical Elements and Oxidative Status in Neuroinflammation 136
Progression of motor subtypes in Huntington’s disease. a 6-year follow-up study 135
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 133
Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders 131
A Mechanistic, Stochastic Model Helps Understand Multiple Sclerosis Course and Pathogenesis 131
Global immune disregulation in multiple sclerosis: from the adaptive response to the innate immunity 130
Noise in multiple sclerosis: unwanted and necessary 129
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 129
Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias 128
A population based study of stroke in Italian Twins. 128
Steps towards collective sustainability in biomedical research 128
Autoimmune encephalitis and CSF anti-glur3 antibodies in an MS patient after alemtuzumab treatment 128
Corrigendum: Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous System (Frontiers in Neuroanatomy, (2020), 14, 10.3389/fnana.2020.00017) 128
Cognitive decline in Huntington's disease expansion gene carriers 128
Survival, mortality, causes and places of death in a european huntington's disease prospective cohort 127
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS 127
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility 125
Multiple sclerosis etiology: beyond genes and environment 125
Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis 125
Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome 125
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 124
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 123
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 122
Co-existence of Myelin Oligodendrocyte Glycoprotien Antibody-associated Disease (MOGAD) and Spinocerebellar Ataxia type 1 (SCA1): A case report 121
determinant spreading without disease progression in multiple sclerosis 121
Irritability in huntington's disease: factor analysis of Snaith's irritability scale 121
Serum elements and oxidative status in clinically isolated syndromes Imbalance and predictivity 121
Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease 120
A Nationwide Study of Multiple Sclerosis in Italian Twins-Session: Complex Disorders II and Immunology 120
A clinical and epidemiological prevalence study on Friedreich’s Ataxia in Latium, Italy 120
T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's disease 119
Downregulation of cell-surface CD4 coreceptor expression and modulation of experimental allergic encephalomyelitis 119
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. 118
Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial 118
Multiple sclerosis: pharmacogenomics and personalised drug treatment. 117
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 116
Characterization of Epstein-Barr virus genotypes in multiple sclerosis 115
Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis 115
Leptomeningitis in a person with radiologically isolated syndrome and latent tuberculosis. A case report with implications for clinical research 115
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. 113
Perivascular unit: this must be the place. The anatomical crossroad between the immune, vascular and nervous system 113
Heat shock proteins and multiple sclerosis 111
T LYMPHOCYTE RESPONSE TO POTENTIAL AUTOANTIGENS IN PATIENTS WITH MULTIPLE SCLEROSIS. 110
Use of Bacille Calmette-Guèrin (BCG) in Multiple Sclerosis 110
Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington's disease gene expansion carriers 110
Totale 14.326
Categoria #
all - tutte 62.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 703
selected - selezionate 0
volume - volumi 0
Totale 63.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 0 0 25
2021/20222.059 42 117 168 85 363 68 43 177 155 129 310 402
2022/20231.889 359 348 94 217 217 188 29 131 182 39 65 20
2023/20241.026 56 113 20 71 82 177 74 107 13 114 106 93
2024/20253.668 111 258 131 166 179 334 219 168 523 337 281 961
2025/20268.423 921 339 577 794 919 443 1.188 451 714 1.005 641 431
Totale 21.982